Browse our range of publications including performance and financial statement audit reports, assurance review reports, information reports and annual reports.
This page lists completed performance audit reports. View all performance audits in-progress.
The ANAO's purpose was to report on:
- the HIC's management of approaches to minimise medifraud and inappropriate practice;
- HIC's reporting of its performance on these matters to stakeholders;
- the methodology used by the HIC to estimate the extent of fraud and inappropriate practice, including comment on the reliability of the estimates; and
- the HIC's implementation of the major recommendations from Medifraud and Excessive Servicing - Audit Report No.17 1992-93.
The purpose of the audit was to examine the efficiency, effectiveness and accountability of the Therapeutic Goods Administration's performance in evaluating and approving prescription drugs for public use. In particular the audit focused on analysing elements of the regulatory process associated with the evaluation of prescription drugs. In this context the audit reviewed the administrative operations performed within the Department's Drug Safety and Evaluation Branch, the Australian Drug Evaluation Committee and the Business and Services Branch of the TGA, rather than any processes preceding or succeeding those activities.
The ANAO's purpose was to ascertain:
- whether the enhanced investigatory powers had improved the Commission's ability to investigate and prosecute fraud and other offences against Health Legislation; and
- whether the Commission had used the powers with integrity, in a professional manner and in accordance with the legislation.